Delivering more actionable and strategically valuable research, The Business Research Company’s 2026 market reports feature market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights.

The stents market has experienced significant growth in recent years, driven by advancements in medical technology and increasing demand for cardiovascular treatments. As healthcare infrastructures improve and new innovations emerge, this sector is poised for continued expansion. Below, we explore the current market size, key factors fueling growth, segmentation details, technological trends, leading players, and regional dynamics shaping the future of the stents industry.

Stents Market Size Overview and Growth Forecast

The stents market has shown strong expansion recently, with its value rising from $11.81 billion in 2025 to $12.49 billion in 2026, representing a compound annual growth rate (CAGR) of 5.8%. This historical growth is linked to limited options for stent materials, widespread use of bare-metal stents, a rising incidence of coronary artery disease, enhanced hospital infrastructure, and increased adoption of angioplasty procedures. Looking ahead, the market is expected to grow to $15.62 billion by 2030, maintaining a CAGR of 5.7%. Factors contributing to this future growth include the development of drug-eluting and bioabsorbable stents, expansion in neurovascular and peripheral interventions, rising investments in stent research and development, an aging population with cardiovascular issues, and the integration of smart and AI-assisted stent deployment technologies. Key trends anticipated during the forecast period involve broader use of drug-eluting and bioabsorbable stents, increased peripheral and neurovascular stent applications, emphasis on minimally invasive and endovascular surgeries, growing demand for customized stents, and improved regulatory and post-market monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=24408&type=smp

Primary Health Factors Driving Growth in the Stents Market

An important driver of the stents market is the rising prevalence of cardiovascular disorders, which affect heart and blood vessel function, leading to impaired circulation and heart performance. Sedentary lifestyles contribute to obesity, hypertension, and cardiovascular deterioration, heightening the need for effective treatments. Stent placement plays a critical role by reopening and maintaining blood flow through narrowed or blocked arteries, thereby preventing heart attacks and other serious complications. For instance, in January 2025, the British Heart Foundation reported that about 7.6 million people in the UK were living with heart and circulatory diseases, consisting of roughly 4 million men and 3.6 million women. These conditions account for nearly 27% of all deaths in the country, equating to over 170,000 fatalities annually or approximately 480 deaths every day. This widespread burden of cardiovascular disease is a strong factor propelling demand for stents.

Breakdown of Stents Market Segmentation and Revenue Sources

This report segments the stents market by product, material, and end user categories. Product-wise, it includes coronary stents, peripheral stents, stent-related implants, biliary stents, carotid stents, and neurovascular stents. The materials used are categorized as metallic biomaterials and polymer biomaterials. End users consist of hospitals and clinics, ambulatory surgical centers, and other healthcare providers. Further product subsegments include drug-eluting, bare-metal, and bioabsorbable coronary stents; iliac artery, femoral-popliteal artery, renal artery, and tibial artery peripheral stents; stent grafts such as endovascular and covered stents; plastic, metallic, and self-expanding biliary stents; balloon-expandable and self-expanding carotid stents; and neurovascular stents including flow diverter, self-expanding, and balloon-expandable types.

Access The Complete Stents Market Report:

https://www.thebusinessresearchcompany.com/report/stents-global-market-report

Innovations and Technological Advances Shaping the Stents Market

Key players in the stents industry are focusing heavily on innovation to improve the performance and safety of their products. Drug-eluting stents, which slowly release medication to prevent artery re-narrowing after placement, are a major area of development. For example, in April 2023, Terumo Europe N.V. introduced the Ultimaster Nagomi sirolimus-eluting coronary stent system, designed for complex percutaneous coronary intervention (PCI) cases. This stent system aims to enhance deliverability in difficult anatomies, support shorter dual-antiplatelet therapy for patients at high bleeding risk, and maintain strong radial support. It features advanced polymer technology for consistent drug release and improved endothelial healing, reflecting the ongoing trend toward smarter, more effective stent solutions.

Leading Companies Shaping the Stents Industry Landscape

The competitive landscape of the stents market includes several prominent organizations such as Abbott Laboratories, Medtronic plc, Boston Scientific Corporation, Terumo Corporation, B Braun Melsungen AG, Cook Medical, Biotronik SE and Co KG, MicroPort Scientific Corporation, Meril Life Sciences, Biosensors International Group Ltd, Elixir Medical Corporation, Veryan Medical Limited, Vascular Concepts Ltd, Novatech SA, Merit Medical Systems Inc, Teleflex Incorporated, Micro Tech Europe, Balton Sp z oo, Endologix Inc, Cardinal Health Interventional, Nipro Medical Corporation, and Optimed Medizinische Instrumente GmbH. These companies are competing through product innovation, strategic partnerships, and expansion of market reach.

Regional Insights and Revenue Leadership in the Stents Market

In 2025, North America held the largest share of the stents market, supported by advanced healthcare infrastructure and high patient awareness. Meanwhile, the Asia-Pacific region is expected to exhibit the fastest growth during the forecast period, driven by improving healthcare facilities, increasing patient population, and rising investments in medical technology. The report covers detailed regional analysis across Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, providing a comprehensive view of the global market landscape.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model